Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted mice.

[1]  M. Qiao,et al.  Disseminated enterovirus infection in a patient treated with obinutuzumab , 2021, Journal of medical virology.

[2]  O. Pabst,et al.  The immune landscape of IgA induction in the gut , 2021, Seminars in Immunopathology.

[3]  Kuo-Feng Weng,et al.  Enterovirus A71 Induces Neurological Diseases and Dynamic Variants in Oral Infection of Human SCARB2-Transgenic Weaned Mice , 2021, Journal of virology.

[4]  Hanzhong Wang,et al.  A Single Mutation in the VP1 Gene of Enterovirus 71 Enhances Viral Binding to Heparan Sulfate and Impairs Viral Pathogenicity in Mice , 2020, Viruses.

[5]  S. Koike,et al.  Heparan sulfate attachment receptor is a major selection factor for attenuated enterovirus 71 mutants during cell culture adaptation , 2020, PLoS pathogens.

[6]  V. Lee,et al.  Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice , 2019, PLoS pathogens.

[7]  N. Baumgarth,et al.  B-1 cell responses to infections. , 2019, Current opinion in immunology.

[8]  N. Baumgarth,et al.  The Multifaceted B Cell Response to Influenza Virus , 2019, The Journal of Immunology.

[9]  P. Meylan,et al.  A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism , 2018, PLoS pathogens.

[10]  K. Fujii,et al.  VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection , 2018, Journal of Virology.

[11]  K. Fujii,et al.  Amino Acid Variation at VP1-145 of Enterovirus 71 Determines Attachment Receptor Usage and Neurovirulence in Human Scavenger Receptor B2 Transgenic Mice , 2018, Journal of Virology.

[12]  Ying Zhu,et al.  Fibronectin Facilitates Enterovirus 71 Infection by Mediating Viral Entry , 2018, Journal of Virology.

[13]  J. Chu,et al.  Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis , 2018, PLoS pathogens.

[14]  O. Paltiel,et al.  Enteroviral infection in patients treated with rituximab for non‐Hodgkin lymphoma: a case series and review of the literature , 2017, Hematological oncology.

[15]  V. Lee,et al.  VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. , 2017, Virology.

[16]  D. Levy-bruhl,et al.  Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016 , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[17]  H. Mentzel,et al.  A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany. , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[18]  Jing-xin Li,et al.  Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children , 2016, Expert review of vaccines.

[19]  K. Chua,et al.  Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain) , 2016, Emerging Microbes & Infections.

[20]  Y. Lo,et al.  Cell Surface Nucleolin Facilitates Enterovirus 71 Binding and Infection , 2015, Journal of Virology.

[21]  Yuna Sun,et al.  Cyclophilin A Associates with Enterovirus-71 Virus Capsid and Plays an Essential Role in Viral Infection as an Uncoating Regulator , 2014, PLoS pathogens.

[22]  M. He,et al.  The variations of VP1 protein might be associated with nervous system symptoms caused by enterovirus 71 infection , 2014, BMC Infectious Diseases.

[23]  P. Tien,et al.  Cell Surface Vimentin Is an Attachment Receptor for Enterovirus 71 , 2014, Journal of Virology.

[24]  J. Whitmire,et al.  B Cell Depletion Curtails CD4+ T Cell Memory and Reduces Protection against Disseminating Virus Infection , 2014, The Journal of Immunology.

[25]  Yingying Zhang,et al.  A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China , 2014, Virus Genes.

[26]  K. Fujii,et al.  Transgenic mouse model for the study of enterovirus 71 neuropathogenesis , 2013, Proceedings of the National Academy of Sciences.

[27]  Hyunwook Lee,et al.  Enterovirus 71 Binding to PSGL-1 on Leukocytes: VP1-145 Acts as a Molecular Switch to Control Receptor Interaction , 2013, PLoS pathogens.

[28]  I. Sam,et al.  Enterovirus 71 Uses Cell Surface Heparan Sulfate Glycosaminoglycan as an Attachment Receptor , 2012, Journal of Virology.

[29]  E. Zdobnov,et al.  Identification of Site-Specific Adaptations Conferring Increased Neural Cell Tropism during Human Enterovirus 71 Infection , 2012, PLoS pathogens.

[30]  C. Chiu,et al.  Genetic characterization of enterovirus 71 isolated from patients with severe disease by comparative analysis of complete genomes , 2012, Journal of medical virology.

[31]  Keiichiro Suzuki,et al.  The Inhibitory Receptor PD-1 Regulates IgA Selection and Bacterial Composition in the Gut , 2012, Science.

[32]  Jen-Ren Wang,et al.  Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. , 2012, Virology.

[33]  Xuejun Ma,et al.  Simultaneously Typing Nine Serotypes of Enteroviruses Associated with Hand, Foot, and Mouth Disease by a GeXP Analyzer-Based Multiplex Reverse Transcription-PCR Assay , 2011, Journal of Clinical Microbiology.

[34]  Q. Zou,et al.  Molecular Analysis of Virulent Determinants of Enterovirus 71 , 2011, PloS one.

[35]  M. Ho,et al.  Annexin II Binds to Capsid Protein VP1 of Enterovirus 71 and Enhances Viral Infectivity , 2011, Journal of Virology.

[36]  Tom Solomon,et al.  Virology, epidemiology, pathogenesis, and control of enterovirus 71. , 2010, The Lancet. Infectious diseases.

[37]  F. Baron,et al.  Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B‐cell lymphoma , 2010, British journal of haematology.

[38]  Kuender D Yang,et al.  Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells , 2009, Virology Journal.

[39]  S. Koike,et al.  Scavenger receptor B2 is a cellular receptor for enterovirus 71 , 2009, Nature Medicine.

[40]  M. Shimojima,et al.  Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71 , 2009, Nature Medicine.

[41]  B. Chua,et al.  The molecular basis of mouse adaptation by human enterovirus 71. , 2008, The Journal of general virology.

[42]  Julie K. Pfeiffer,et al.  Multiple Host Barriers Restrict Poliovirus Trafficking in Mice , 2008, PLoS pathogens.

[43]  K. Wong,et al.  Pathologic Characterization of a Murine Model of Human Enterovirus 71 Encephalomyelitis , 2008, Journal of neuropathology and experimental neurology.

[44]  T. Wakita,et al.  Cooperative Effect of the Attenuation Determinants Derived from Poliovirus Sabin 1 Strain Is Essential for Attenuation of Enterovirus 71 in the NOD/SCID Mouse Infection Model , 2007, Journal of Virology.

[45]  Jen-Ren Wang,et al.  Retrograde Axonal Transport: a Major Transmission Route of Enterovirus 71 in Mice , 2007, Journal of Virology.

[46]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[47]  H. Lei,et al.  A Mouse-Adapted Enterovirus 71 Strain Causes Neurological Disease in Mice after Oral Infection , 2004, Journal of Virology.

[48]  J. Esko,et al.  Contribution of Proteoglycans to Human Immunodeficiency Virus Type 1 Brain Invasion , 2004, Journal of Virology.

[49]  A. Fischer,et al.  Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  M. Georgescu,et al.  Random selection: a model for poliovirus infection of the central nervous system. , 1997, The Journal of general virology.

[51]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[52]  M. von Itzstein,et al.  Heparan sulfate analogues act as decoy receptors and efficiently block enterovirus 71 infection. , 2019, ACS infectious diseases.

[53]  T. Berg,et al.  [Diagnosis and clinical features of infection with hepatitis A and hepatitis E viruses. Transmission through drinking water and foodstuffs]. , 2011, Pharmazie in unserer Zeit.